Skip to Content
MilliporeSigma
  • Action of calcium antagonists and agonists on isolated human thoracic arteries used for coronary artery bypass grafting.

Action of calcium antagonists and agonists on isolated human thoracic arteries used for coronary artery bypass grafting.

Pharmacological reports : PR (2012-07-21)
Vida Garaliene, Vygantas Barsys, Povilas Jakuška, Rimantas Benetis
ABSTRACT

The goal of this study was to investigate the modulation of the contraction-relaxation effects in isolated human thoracic artery samples of three calcium-channel antagonists, amlodipine (CAS [88150-42-9]), cerebrocrast (CAS [118790-71-9]) and diltiazem (CAS [42399-41-7]), and two calcium-channel agonists, CGP 28392 (CAS [89289-93-0]) and benzimidazole derivative. To estimate the endothelial function of the artery samples, carbachol, an agonist of muscarinic receptors, was used. The experiments were conducted on isolated human thoracic artery samples, and their isometric contractions were recorded using an i-FOT10 force transducer. Cumulative concentration-contraction curves of the tested agents (10(-7) to 10(-4) M) were established. Carbachol at concentrations of 10(-7) to 10(-6) M did not cause any relaxation of artery rings precontracted by 10(-4) M phenylephrine, and at concentrations of 10(-5) and 10(-4) M, isometric contractions increased by 7% and 20%, respectively. In response to amlodipine, cerebrocrast and CGP28392, the contraction of artery samples increased significantly, whereas diltiazem and benzimidazole derivative caused their relaxation by ≈55%. The obtained data indicate that the endothelium of the thoracic artery, which is used for coronary artery bypass grafting, is damaged by and may have some influence on the inadequate response of 1,4-dihydropyrine type calcium-channel antagonists.

MATERIALS
Product Number
Brand
Product Description

Supelco
Diltiazem hydrochloride solution, 1.0 mg/mL in acetonitrile (as free base), ampule of 1 mL, certified reference material, Cerilliant®
Diltiazem hydrochloride, European Pharmacopoeia (EP) Reference Standard
Diltiazem for system suitability, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
(+)-cis-Diltiazem hydrochloride, ≥99% (HPLC)